arrow
F

Frédéric Perros

Inserm
H指数:57
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pulmonary hypertension induced by right pulmonary artery occlusion: hemodynamic consequences of Bmpr2 mutation

右肺动脉阻塞引起的肺动脉高压: Bmpr2突变的血流动力学后果

2024-10-300
PRE
Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension

肺中的整合多组学揭示了Asporin在肺动脉高压中的保护作用

2024-10-151
PRE
Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation

右肺动脉阻塞引起的肺动脉高压: Bmpr2突变的血流动力学后果

2024-07-161
OAAI
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness
2024-06-013
PRE
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors

与蛋白酶体抑制剂相关的肺动脉高压患者的特征和预后

2024-05-021
PRE
T-cell dysregulation and inflammatory process in Gcn2 (Eif2ak4-/-)-deficient rats in basal and stress conditions

基础和应激条件下Gcn2 (Eif2ak4-/-) 缺陷大鼠的T细胞失调和炎症过程

2023-05-011
OA
Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension

右心导管监测儿童肺动脉高压的血流动力学

2023-04-046
OAAI
Molecular Function and Contribution of TBX4 in Development and Disease

TBX4在发育和疾病中的分子功能及其贡献

2023-04-0110
OA
Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis
2023-03-018
OA
An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants

携带SOX17变体的肺动脉高压患者的新兴表型

2022-05-2622
OAAI
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2 (vol 4, 1002, 2021)
2022-01-200
OAAI